Article: | MedLuna.com

Overview

Journal Laryngorhinootologie

Publisher Thieme

Specialty Otorhinolaryngology

Date 2020 May 9

PMID 32384572

Citations 6

Authors

L Klimek

S Becker

R Buhl

A M Chaker

T Huppertz

T K Hoffmann

S Dazert

T Deitmer

U Forster-Ruhrmann

H Olze

J Hagemann

S K Plontke

H Wrede

W Schlenter

H J Welkoborsky

B Wollenberg

A G Beule

C Rudack

S Strieth

R Mosges

C Bachert

T Stover

C Matthias

A Dietz

Affiliations

Soon will be listed here.

Citing Articles

Monitoring mepolizumab treatment in chronic rhinosinusitis with nasal polyps (CRSwNP): Discontinue, change, continue therapy?.

Klimek L, Forster-Ruhrmann U, Olze H, Beule A, Chaker A, Hagemann J Allergol Select. 2024; 8:26-39.

PMID: 38549814 PMC: 10975744. DOI: 10.5414/ALX02460E.

Recommendations for use of topical inhalant budesonide in COVID-19 : A Position Paper of the German Society for Applied Allergology (AeDA) and the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNO).

Klimek L, Buhl R, Deitmer T, Plontke S, Wehrmann W, Merk H HNO. 2021; 69(Suppl 2):35-38.

PMID: 34272571 PMC: 8284416. DOI: 10.1007/s00106-021-01070-9.

[Recommendations for use of topical inhalant budesonide in COVID-19 : A position paper of the German Society for Applied Allergology (AeDA) and the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNO). German version].

Klimek L, Buhl R, Deitmer T, Plontke S, Wehrmann W, Merk H HNO. 2021; 69(8):611-614.

PMID: 34142164 PMC: 8210958. DOI: 10.1007/s00106-021-01084-3.

[Dupilumab has an additional benefit in treatment of chronic rhinosinusitis with nasal polyps].

Klimek L, Chaker A, Deitmer T, Plontke S, Wollenberg B, Bousquet J HNO. 2021; 69(11):868-877.

PMID: 33738558 PMC: 7971351. DOI: 10.1007/s00106-021-01018-z.

Klimek L, Worm M, Lange L, Beyer K, Rietschel E, Vogelberg C Allergo J. 2020; 29(7):16-26.

PMID: 33162681 PMC: 7605140. DOI: 10.1007/s15007-020-2618-y.

References

Hastan D, Fokkens W, Bachert C, Newson R, Bislimovska J, Bockelbrink A . Chronic rhinosinusitis in Europe--an underestimated disease. A GA²LEN study. Allergy. 2011; 66(9):1216-23. DOI: 10.1111/j.1398-9995.2011.02646.x. View

Rondon C, Davila I, Navarro Pulido A, Sanchez M, Montoro J, Matheu V . Clinical Management and Use of Health Care Resources in the Treatment of Nasal Polyposis in Spanish Allergy Centers: The POLAR Study. J Investig Allergol Clin Immunol. 2015; 25(4):276-82. View

Seys S, Scheers H, Van den Brande P, Marijsse G, Dilissen E, Van Den Bergh A . Cluster analysis of sputum cytokine-high profiles reveals diversity in T(h)2-high asthma patients. Respir Res. 2017; 18(1):39. PMC: 5324270. DOI: 10.1186/s12931-017-0524-y. View

Luers J, Klussmann J, Guntinas-Lichius O . [The COVID-19 pandemic and otolaryngology: What it comes down to?]. Laryngorhinootologie. 2020; 99(5):287-291. DOI: 10.1055/a-1095-2344. View

Vaira L, Salzano G, Deiana G, De Riu G . Anosmia and Ageusia: Common Findings in COVID-19 Patients. Laryngoscope. 2020; 130(7):1787. PMC: 7228304. DOI: 10.1002/lary.28692. View

Head K, Chong L, Hopkins C, Philpott C, Burton M, Schilder A . Short-course oral steroids alone for chronic rhinosinusitis. Cochrane Database Syst Rev. 2016; 4:CD011991. PMC: 8504433. DOI: 10.1002/14651858.CD011991.pub2. View

Workman A, Welling D, Carter B, Curry W, Holbrook E, Gray S . Endonasal instrumentation and aerosolization risk in the era of COVID-19: simulation, literature review, and proposed mitigation strategies. Int Forum Allergy Rhinol. 2020; 10(7):798-805. DOI: 10.1002/alr.22577. View

Fokkens W . EPOS2020: a major step forward. Rhinology. 2020; 58(1):1. DOI: 10.4193/Rhin20.401. View

Hox V, Lourijsen E, Jordens A, Aasbjerg K, Agache I, Alobid I . Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper. Clin Transl Allergy. 2020; 10:1. PMC: 6941282. DOI: 10.1186/s13601-019-0303-6. View

10.

Pouliquen I, Kornmann O, Barton S, Price J, Ortega H . Characterization of the relationship between dose and blood eosinophil response following subcutaneous administration of mepolizumab. Int J Clin Pharmacol Ther. 2015; 53(12):1015-27. PMC: 4647865. DOI: 10.5414/CP202446. View

11.

Koennecke M, Klimek L, Mullol J, Gevaert P, Wollenberg B . Subtyping of polyposis nasi: phenotypes, endotypes and comorbidities. Allergo J Int. 2018; 27(2):56-65. PMC: 5842507. DOI: 10.1007/s40629-017-0048-5. View

12.

Fokkens W . Evidence-based and precision medicine two of a kind. Rhinology. 2017; 55(1):1-2. DOI: 10.4193/Rhin17.401. View

13.

Fokkens W, Lund V, Mullol J, Bachert C, Alobid I, Baroody F . European Position Paper on Rhinosinusitis and Nasal Polyps 2012. Rhinol Suppl. 2012; 23. View

14.

Fokkens W, Lund V, Hopkins C, Hellings P, Kern R, Reitsma S . European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020; 58(Suppl S29):1-464. DOI: 10.4193/Rhin20.600. View

15.

Tomassen P, Vandeplas G, Van Zele T, Cardell L, Arebro J, Olze H . Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers. J Allergy Clin Immunol. 2016; 137(5):1449-1456.e4. DOI: 10.1016/j.jaci.2015.12.1324. View

16.

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229):1054-1062. PMC: 7270627. DOI: 10.1016/S0140-6736(20)30566-3. View

17.

Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y . Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020; 146(1):110-118. PMC: 7152876. DOI: 10.1016/j.jaci.2020.04.006. View

18.

Dreher M, Kersten A, Bickenbach J, Balfanz P, Hartmann B, Cornelissen C . The Characteristics of 50 Hospitalized COVID-19 Patients With and Without ARDS. Dtsch Arztebl Int. 2020; 117(16):271-278. PMC: 7171478. DOI: 10.3238/arztebl.2020.0271. View

19.

Green R, Brightling C, Woltmann G, Parker D, Wardlaw A, Pavord I . Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax. 2002; 57(10):875-9. PMC: 1746199. DOI: 10.1136/thorax.57.10.875. View

20.

Darveaux J, Lemanske Jr R . Infection-related asthma. J Allergy Clin Immunol Pract. 2014; 2(6):658-63. PMC: 5516525. DOI: 10.1016/j.jaip.2014.09.011. View